Compare Abbott Laboratories (ABT) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs PPG Industries, Inc. — how do they compare? Abbott Laboratories trades at $95.76 (market cap $166.94B), while PPG Industries, Inc. trades at $114.26 (market cap $26.80B). The key difference: Abbott Laboratories is far larger — about 6.2× PPG Industries, Inc.'s market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | PPG | |
|---|---|---|
Market Cap | $166.94B | $26.80B |
Sector | Health | Basic Materials |
52-Week High | $136.62 | $131.56 |
52-Week Low | $82.57 | $94.34 |
Enterprise Value | $193.69B | $32.90B |
Dividend Yield | 2.63% | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
PPG Industries (PPG) trades at $120.22, down 4.08% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings of $1.83 per share, beating estimates, and maintains solid profitability with a net margin of 9.83% and ROE of 21.09%. Recent news highlights innovation in aerospace and marine coatings, including a green chemistry award for SIGMAGLIDE 2390 coating.
The outlook is supported by analyst consensus with a $129.40 price target and 52.63% buy ratings, but risks include volume softness and margin pressure. Earnings growth and sustainability initiatives are key catalysts, though macroeconomic headwinds and competitive pressures remain concerns for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
